These dendritic cells produced IL-12 upon sensing the IFN-γ released from T cells, which in turn promoted effector T-cell responses in both mice and patients with cancer.14 The present study provides evidence that the activated T-cell reprogramming of MDSCs is essential for the response to anti-PD-1 treatment in CRC tumors. The gene discussed is IFNG; the disease is cancer.